基本信息

李尹雄  男  博导  中国科学院广州生物医药与健康研究院
电子邮件: li_yinxiong@gibh.ac.cn
通信地址: 广州市萝岗区开源大道190号
邮政编码: 510530

研究领域

· 肝脏发育和成体肝脏干细胞的分子调控机理研究;

· 环境因素及酒精的先天致畸原理和预防研究;

· 组织修复,纤维化及成体干细胞功能的调控探讨;

· 人群中胆固醇状况,Hedgehog信息通路与成体干细胞健康和老化研究

·  生物标志物筛选和疾病基因诊断的研发


招生信息

   
招生专业
071010-生物化学与分子生物学
招生方向
干细胞与组织修复和再生

教育背景

1987-09--1991-06   协和医科大学   博士
1979-09--1985-06   中南大学湘雅医学院   学士

教授课程

分子发育学
分子发育学和细胞生物学

专利与奖励

   
专利成果
[1] 李尹雄, 王宁, 庄苑琦, 袁方. 一种抗体及其制备方法和应用. CN: CN111499739B, 2022-03-25.

[2] 李尹雄, 陈彦, 游凯, 谭圣林. 一种病毒性肺炎的标志物及其应用. CN: CN113376386A, 2021-09-10.

[3] 李尹雄, 熊月, 方霁. 一种人胰高血糖素样肽-1受体激活剂及其应用. CN: CN112451515A, 2021-03-09.

[4] 李尹雄, 游凯. SAA抑制剂在制备治疗急性肝损伤、急性肝衰竭或慢加急性肝衰竭的药物中的应用. CN: CN111920953A, 2020-11-13.

[5] 李尹雄, 潘廷才, 陈彦, 庄苑琦, 杨帆. 一种培养扩增人肝祖细胞的培养基及其应用. CN: CN111607556A, 2020-09-01.

[6] 李尹雄, 伍飞马, 陈彦, 谭圣林, 潘廷才. 一种淘选和扩增培养肝脏干细胞的方法及其应用. CN: CN111500528A, 2020-08-07.

[7] 吴芬芳, 陈立勇, 寇尚龙, 侯健, 李尹雄. 一种CIDE3多肽及其抗体的制备和应用. CN: CN104311654A, 2015-01-28.

出版信息

   
发表论文
[1] You, Kai, Wang, Yan, Chen, Xiaoxia, Yang, Zhen, Chen, Yan, Tan, Shenglin, Tao, Jiawang, Getachew, Anteneh, Pan, Tingcai, Xu, Yingying, Zhuang, Yuanqi, Yang, Fan, Lin, Xianhua, Li, Yinxiong. Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS[J]. 2023, 639: 20-28, http://dx.doi.org/10.1016/j.bbrc.2022.11.079.
[2] Pan, Tingcai, Wang, Ning, Zhang, Jiaye, Yang, Fan, Chen, Yan, Zhuang, Yuanqi, Xu, Yingying, Fang, Ji, You, Kai, Lin, Xianhua, Li, Yang, Li, Shao, Liang, Kangyan, Li, YinXiong, Gao, Yi. Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy. STEM CELL RESEARCH & THERAPY[J]. 2022, 13(1): http://dx.doi.org/10.1186/s13287-022-02831-1.
[3] Tao, Jiawang, Chen, Yan, Zhuang, Yuanqi, Wei, Ruzhi, Getachew, Anteneh, Pan, Tingcai, Yang, Fan, Li, Yinxiong. Inhibition of Hedgehog Delays Liver Regeneration through Disrupting the Cell Cycle. CURRENT ISSUES IN MOLECULAR BIOLOGY[J]. 2022, 44(2): 470-482, http://dx.doi.org/10.3390/cimb44020032.
[4] Li, Penghui, Liu, Ying, Cheng, Ziqi, Yu, Xiaorui, Li, Yinxiong. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management. BIOMEDICINE & PHARMACOTHERAPYnull. 2022, 154: http://dx.doi.org/10.1016/j.biopha.2022.113568.
[5] Yang, Zhen, Huang, Xinping, Zhang, Jiaye, You, Kai, Xiong, Yue, Fang, Ji, Getachew, Anteneh, Cheng, Ziqi, Yu, Xiaorui, Wang, Yan, Wu, Feima, Wang, Ning, Feng, Shufen, Lin, Xianhua, Yang, Fan, Chen, Yan, Wei, Hongcheng, Li, Yinxiong. Hepatic DKK1-driven steatosis is CD36 dependent. LIFE SCIENCE ALLIANCE[J]. 2022, 6(2): http://dx.doi.org/10.26508/lsa.202201665.
[6] Cheng, Ziqi, Guo, Dongsheng, Ruzi, Aynisahan, Pan, Tingcai, You, Kai, Chen, Yan, Huang, Xinping, Zhang, Jiaye, Yang, Fan, Niu, Lizhi, Xu, Kecheng, Li, YinXiong. Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin. CELLS[J]. 2022, 11(15): http://dx.doi.org/10.3390/cells11152387.
[7] Yue Xiong, Yan Chen, Xinping Huang, Zhen Yang, Jiaye Zhang, Xiaorui Yu, Ji Fang, Jiawang Tao, Kai You, Ziqi Cheng, Shenglin Tan, Yingying Xu, Fang Yuan, Ying Liu, Yuanqi Zhuang, Fan Yang, Yinxiong Li. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. LIFE SCIENCES. 2021, 268: http://dx.doi.org/10.1016/j.lfs.2020.119000.
[8] Pan, Tingcai, Tao, Jiawang, Chen, Yan, Zhang, Jiaye, Getachew, Anteneh, Zhuang, Yuanqi, Wang, Ning, Xu, Yingying, Tan, Shenglin, Fang, Ji, Yang, Fan, Lin, Xianhua, You, Kai, Gao, Yi, Li, Yinxiong. Robust expansion and functional maturation of human hepatoblasts by chemical strategy. STEM CELL RESEARCH & THERAPY[J]. 2021, 12(1): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908723/.
[9] Getachew, Anteneh, Abbas, Nasir, You, Kai, Yang, Zhen, Hussain, Muzammal, Huang, Xinping, Cheng, Ziqi, Tan, Shenglin, Tao, Jiawang, Yu, Xiaorui, Chen, Yan, Yang, Fan, Pan, Tingcai, Xu, Yingying, Xu, Guosheng, Zhuang, Yuanqi, Wu, FeiMa, Li, Yinxiong. SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury. ISCIENCE[J]. 2021, 24(5): http://dx.doi.org/10.1016/j.isci.2021.102483.
[10] Yuan, Fang, Wang, Ning, Chen, Yan, Huang, Xinping, Yang, Zhen, Xu, Yingying, You, Kai, Zhang, Jiaye, Wang, Guodong, Zhuang, Yuanqi, Pan, Tingcai, Xiong, Yue, Yu, Xiaorui, Yang, Fan, Li, Yinxiong. Calcitriol promotes the maturation of hepatocyte-like cells derived from human pluripotent stem cells. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY[J]. 2021, 211: http://dx.doi.org/10.1016/j.jsbmb.2021.105881.
[11] Getachew, Anteneh, Hussain, Muzammal, Huang, Xinping, Li, Yinxiong. Toll-like receptor 2 signaling in liver pathophysiology. LIFE SCIENCESnull. 2021, 284: http://dx.doi.org/10.1016/j.lfs.2021.119941.
[12] Wu, Feima, Chen, Yan, You, Kai, Tan, Shenglin, Xu, Yingying, Wang, PeiHui, Liu, Shiming, Li, Yinxiong. Generation of WAe001-A-58 human embryonic stem cell line with inducible expression of the SARS-CoV-2 nucleocapsid protein. STEM CELL RESEARCH[J]. 2021, 53: http://dx.doi.org/10.1016/j.scr.2021.102197.
[13] Yang, Zhen, Yuan, Fang, Wang, Ning, Liu, Yanli, Zhang, Jiaye, Wei, Ruzhi, Wu, FeiMa, Wu, Yuhang, You, Kai, Chen, Yan, Yang, Fan, Li, YinXiong. Generation of a DKK1 homozygous knockout human embryonic stem cell line WAe001-A-21 using CRISPR/Cas9. STEM CELL RESEARCH[J]. 2021, 51: http://dx.doi.org/10.1016/j.scr.2021.102161.
[14] Xu, Yingying, Tao, Jiawang, Yu, Xiaorui, Wu, Yuhang, Chen, Yan, You, Kai, Zhang, Jiaye, Getachew, Anteneh, Pan, Tingcai, Zhuang, Yuanqi, Yuan, Fang, Yang, Fan, Lin, Xianhua, Li, Yinxiong. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI INSIGHT[J]. 2021, 6(19): [15] Getachew, Anteneh, Yang, Zhen, Huang, Xinping, Wu, Feima, Liu, Yan Ying, Yan, Chen, Yang, Fan, Li, Yinxiong. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing. STEM CELL RESEARCH[J]. 2021, 54: http://dx.doi.org/10.1016/j.scr.2021.102401.
[16] Xiong, Yue, Chen, Yan, Huang, Xinping, Yang, Zhen, Zhang, Jiaye, Yu, Xiaorui, Fang, Ji, Tao, Jiawang, You, Kai, Cheng, Ziqi, Tan, Shenglin, Xu, Yingying, Yuan, Fang, Liu, Ying, Zhuang, Yuanqi, Yang, Fan, Li, Yinxiong. Icaritin ameliorates hepatic steatosis via promoting fatty acid beta-oxidation and insulin sensitivity. LIFE SCIENCES[J]. 2021, 268: http://dx.doi.org/10.1016/j.lfs.2020.119000.
[17] Fang Yuan, Yingying Xu, Kai You, Jiaye Zhang, Fan Yang, Yinxiong Li. Calcitriol alleviates ethanol-induced hepatotoxicity via AMPK/mTOR-mediated autophagy. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2021, 697: [18] Anteneh Getachew, Muzammal Hussain, Xinping Huang, Yinxiong Li. Toll-like receptor 2 signaling in liver pathophysiology. LIFE SCIENCES. 2021, 284: http://dx.doi.org/10.1016/j.lfs.2021.119941.
[19] Abbas, Nasir, Getachew, Anteneh, You, Kai, Shah, Zahir, Chen, Yan, Tao, Jiawang, Hussain, Muzammal, Yang, Fan, Zhuang, Yuanqi, Xu, Yingying, Li, YinXiong. Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS[J]. 2020, 529(2): 474-479, http://dx.doi.org/10.1016/j.bbrc.2020.06.041.
[20] Liu, Jingfeng, Pan, Tingcai, Chen, Yan, Liu, Ying, Yang, Fan, Chen, Qu, Abbas, Nasir, Zhong, Mingyan, Zhang, Qianbing, Xu, Yang, Li, Yinxiong. Repair of acute liver damage with immune evasive hESC derived hepatoblasts. STEM CELL RESEARCH[J]. 2020, 49: http://dx.doi.org/10.1016/j.scr.2020.102010.
[21] Liu, Yanli, Zhang, Jiaye, Chen, Yan, Sohel, Hasan, Ke, Xinrong, Chen, Jingqi, Li, YinXiong. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis. AGING-US[J]. 2020, 12(1): 204-223, https://www.webofscience.com/wos/woscc/full-record/WOS:000507233100014.
[22] Xu, Yingying, Wu, Yuhang, Xiong, Yue, Tao, Jiawang, Pan, Tingcai, Tan, Shenglin, Gao, Ge, Chen, Yan, Abbas, Nasir, Getachew, Anteneh, Zhuang, Yuanqi, You, Kai, Yang, Fan, Li, Yinxiong. Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3). NUTRITION & METABOLISM[J]. 2020, 17(1): http://dx.doi.org/10.1186/s12986-020-0431-y.
[23] Hong, Wenxin, Chen, Yan, You, Kai, Tan, Shenglin, Wu, Feima, Tao, Jiawang, Chen, Xudan, Zhang, Jiaye, Xiong, Yue, Yuan, Fang, Yang, Zhen, Chen, Tingting, Chen, Xinwen, Peng, Ping, Tai, Qiang, Wang, Jian, Zhang, Fuchun, Li, YinXiong. Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study. FRONTIERS IN PHARMACOLOGY[J]. 2020, 11: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703865/.
[24] Xu, Guosheng, Wu, Feima, Gu, Xiaotong, Zhang, Jiaye, You, Kai, Chen, Yan, Getachew, Anteneh, Zhuang, Yuanqi, Zhong, Xiaofen, Lin, Zuoxian, Guo, Dongsheng, Yang, Fan, Pan, Tingcai, Wei, Hongcheng, Li, Yinxiong. Direct Conversion of Human Urine Cells to Neurons by Small Molecules. SCIENTIFICREPORTS[J]. 2019, 9(1): http://dx.doi.org/10.1038/s41598-019-53007-6.
[25] Pan, Tingcai, Chen, Yan, Zhuang, Yuanqi, Yang, Fan, Xu, Yingying, Tao, Jiawang, You, Kai, Wang, Ning, Wu, Yuhang, Lin, Xianhua, Wu, Feima, Liu, Yanli, Li, Yingrui, Wang, Guodong, Li, Yinxiong. Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts. STEM CELL RESEARCH & THERAPY[J]. 2019, 10(1): http://dx.doi.org/10.1186/s13287-019-1463-y.
[26] Wu, Feima, Gao, Ge, Pan, Tingcai, Yang, Zhen, Xu, Guosheng, Abbas, Nasir, Liu, Yanli, Chen, Yan, Tan, Shenglin, You, Kai, Ke, Xinrong, Zhuang, Yuanqi, Lin, Xianhua, Yang, Fan, Li, Yinxiong. Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing. STEM CELL RESEARCH[J]. 2018, 27: 5-9, https://www.webofscience.com/wos/woscc/full-record/WOS:000427533700002.
[27] He, Xiangjun, Li, YinXiong, Feng, Bo. New Turns for High Efficiency Knock-In of Large DNA in Human Pluripotent Stem Cells. STEM CELLS INTERNATIONAL[J]. 2018, 2018: https://doaj.org/article/2e27d4096fa14cea954b258f979373e5.
[28] Liu, Yanli, Wu, Feima, Liu, Dong, Wei, Ruzhi, Abbas, Nasir, Xia, Jianhong, Li, Dongwei, Wang, Haiyun, Zhuang, Yuanqi, Guo, Dongsheng, Chen, Yan, Wu, Yuhang, Ke, Xinrong, Tao, Jiawang, Yang, Fan, Lai, Keyu, Shu, Xiaodong, Li, Yinxiong. Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression. STEM CELL RESEARCH[J]. 2018, 29: 84-87, http://dx.doi.org/10.1016/j.scr.2018.03.007.
[29] Wei, Ruzhi, Yuan, Fang, Wu, Yuhang, Liu, Yanli, You, Kai, Yang, Zhen, Chen, Yan, Getachew, Anteneh, Wang, Ning, Xu, Yingying, Zhuang, Yuanqi, Yang, Fan, Li, Yinxiong. Construction of a GLI3 compound heterozygous knockout human embryonic stem cell line WAe001-A-20 by CRISPR/Cas9 editing. STEM CELL RESEARCH[J]. 2018, 32: 139-144, https://www.webofscience.com/wos/woscc/full-record/WOS:000447301200021.
[30] Hou, Jian, Long, Yan, Hu, Bo, Huang, Shaojie, Xu, Guangtao, Gao, Tesheng, Wu, Fenfang, Li, Yinxiong, Wu, Zhongkai. Retaining mTeSR1 Medium during Hepatic Differentiation Facilitates Hepatocyte-Like Cell Survival by Decreasing Apoptosis. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY[J]. 2018, 51(4): 1533-1543, https://doaj.org/article/90bde15a7a4747f483293be3a03d181a.
[31] Yuan, Fang, Guo, Dongsheng, Liu, Yanli, Xu, Yingying, Gao, Ge, Wu, Yuhang, Yang, Fan, Ke, Xinrong, Lai, Keyu, Wei, Hongcheng, Li, YinXiong. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9. STEM CELL RESEARCH[J]. 2018, 26: 67-71, http://dx.doi.org/10.1016/j.scr.2017.11.007.
[32] Xu, Guosheng, Guo, Dongsheng, Wu, Feima, Abbas, Nasir, Lai, Keyu, Yuan, Fang, You, Kai, Liu, Yanli, Zhuang, Yuanqi, Wu, Yuhang, Xu, Yingying, Chen, Yan, Yang, Fan, Pan, Tingcai, Li, Yinxiong. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing. STEM CELL RESEARCH[J]. 2018, 27: 38-41, http://dx.doi.org/10.1016/j.scr.2017.12.009.
[33] Shaoyang Zhao, Jianhong Xia, Xiuhua Wu, Leilei Zhang, Pengtao Wang, Haiyun Wang, Heying Li, Xiaoshan Wang, Yan Chen, Jean Agnetti, Yinxiong Li, Duanqing Pei, Xiaodong Shu. Deficiency in class III PI3-kinase confers postnatal lethality with IBD-like features in zebrafish. NATURE COMMUNICATIONS[J]. 2018, 9(1): https://doaj.org/article/52fb76a738244a3ca021d472454b1daf.
[34] Xu, Yingying, Wu, Yuhang, Guo, Dongsheng, Gao, Ge, Lai, Keyu, Yang, Fan, Wang, Kepin, Wu, Han, Lai, Liangxue, Li, Jialiang, Xu, Kecheng, Li, YinXiong. Generation of an ASGR1 homozygousmutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9. STEM CELL RESEARCH[J]. 2017, 22(C): 29-32, http://apps.webofknowledge.com/CitedFullRecord.do?product=UA&colName=WOS&SID=5CCFccWmJJRAuMzNPjj&search_mode=CitedFullRecord&isickref=WOS:000405469000005.
[35] Guosheng Xu. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing - ScienceDirect. ELSEVIER. 2017, http://oa.las.ac.cn/oainone/service/browseall/read1?ptype=JA&workid=JA201902198514141ZK.
[36] Liu, Yanli, Ruzi, Aynisahan, Guo, Dongsheng, Wu, Feima, Liu, Haikun, Wu, Han, Wu, Yuhang, Yuan, Fang, Zhuang, Yuanqi, Yang, Fan, Lai, Keyu, Lai, Liangxue, Li, Yinxiong. Generation of two MEN1 knockout lines from a human embryonic stem cell line. STEM CELL RESEARCH[J]. 2017, 24(C): 169-173, http://dx.doi.org/10.1016/j.scr.2017.06.005.
[37] Lin, Mao, Xue, XiangYang, Liang, ShuZhen, Li, YinXiong, Lv, YouYong, He, LiHua, Xu, KeCheng, Zhang, LiFang, Chen, JiBing, Niu, LiZhi. MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6. ONCOTARGET[J]. 2017, 8(38): 62914-62926, https://www.webofscience.com/wos/woscc/full-record/WOS:000410284800010.
[38] Yinxiong Li. Modeling Congenital Hyperinsulinism with ABCC8 Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9 Scientific Reports. Stem Cell Research. 2017, [39] Liu, Haikun, Guo, Dongsheng, Ruzi, Aynisahan, Chen, Yan, Pan, Tingcai, Yang, Fan, Li, Jialiang, Xu, Kecheng, Zhou, Tiancheng, Qin, Dajiang, Li, Yinxiong. Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells. PLOS ONE[J]. 2017, 12(6): http://www.corc.org.cn/handle/1471x/2202009.
[40] Xu Yingying, Wu Yuhang, Guo Dongsheng, Gao Ge, Lai Keyu, Yang Fan, Wang Kepin, Wu Han, Lai Liangxue, Li Jialiang, Xu Kecheng, Li Yinxiong. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9. STEM CELL RESEARCH[J]. 2017, [41] Guo, Dongsheng, Wu, Feima, Liu, Haikun, Gao, Ge, Kou, Shanglong, Yang, Fan, Abbas, Nasir, Zhou, Tiancheng, Cai, Xiujuan, Zhang, Hui, Qin, Dajiang, Li, Jialiang, Xu, Kecheng, Li, Yinxiong. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome. STEM CELL RESEARCH[J]. 2017, 18: 64-66, http://dx.doi.org/10.1016/j.scr.2016.12.009.
[42] Cao, Shangtao, Yu, Shengyong, Chen, Yan, Wang, Xiaoshan, Zhou, Chunhua, Liu, Yuting, Kuang, Junqi, Liu, He, Li, Dongwei, Ye, Jing, Qin, Yue, Chu, Shilong, Wu, Linlin, Guo, Lin, Li, Yinxiong, Shu, Xiaodong, Chen, Jiekai, Liu, Jing, Pei, Duanqing. Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage. JOURNAL OF BIOLOGICAL CHEMISTRY[J]. 2017, 292(46): 19122-19132, http://dx.doi.org/10.1074/jbc.M117.812537.
[43] Liu, Yanli, Wu, Feima, Zhuang, Yuanqi, Guo, Dongsheng, Abbas, Nasir, Wei, Ruzi, Wang, Kepin, Chen, Yan, Tao, Jiawang, Wu, Yuhang, Yuan, Fang, Pan, Tingcai, Yang, Fan, Lai, Keyu, Lai, Liangxue, Li, Yinxiong. Generation of three miR-122 knockout lines from a human embryonic stem cell line. STEM CELL RESEARCH[J]. 2017, 24(C): 164-168, https://doaj.org/article/ac0dca841d6544bc8a6e112e3dedb85f.
[44] Yuan, Fang, Guo, Dongsheng, Gaob, Ge, Liu, Yanli, Xu, Yingying, Wu, Yuhang, Yang, Fan, Ke, Xinrong, Lai, Keyu, Hong, Liangqing, Li, Yinxiong. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9. STEM CELL RESEARCH[J]. 2017, 24(C): 89-93, https://doaj.org/article/ebd4bf2139264288bcd665cd49076cae.
[45] Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, Ge Gao, Abbas Nasir, Yanli Liu, Fan Yang, Feima Wu, Guosheng Xu, Yinxiong Li. Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9. SCIENTIFIC REPORTS[J]. 2017, 7(1): https://doaj.org/article/2eef6fa0dafc4b3492d08947d95ff76c.
[46] Guo, Dongsheng, Wu, Feima, Liu, Haikun, Gao, Ge, Kou, Shanglong, Yang, Fan, Abbas, Nasir, Zhou, Tiancheng, Cai, Xiujuan, Zhang, Hui, Qin, Dajiang, Li, Jialiang, Xu, Kecheng, Li, Yinxiong. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome. STEM CELL RESEARCH[J]. 2017, 18: 70-72, http://dx.doi.org/10.1016/j.scr.2016.12.002.
[47] Li, Qiuhong, Hutchins, Andrew P, Chen, Yong, Li, Shengbiao, Shan, Yongli, Liao, Baojian, Zheng, Dejin, Shi, Xi, Li, Yinxiong, Chan, WaiYee, Pan, Guangjin, Wei, Shicheng, Shu, Xiaodong, Pei, Duanqing. A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes. NATURE COMMUNICATIONS[J]. 2017, 8(1): https://doaj.org/article/cec18cac0b1e41b2b6dcfc9392783321.
[48] Guo, Dongsheng, Liu, Haikun, Gao, Ge, Liu, Yanli, Zhuang, Yuanqi, Yang, Fan, Wang, Kepin, Zhou, Tiancheng, Qin, Dajiang, Hong, Liangqing, Li, Jialiang, Xu, Kecheng, Li, Yinxiong. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN. STEM CELL RESEARCH[J]. 2017, 18: 67-69, https://www.webofscience.com/wos/woscc/full-record/WOS:000396392000017.
[49] Yinxiong Li. A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes Nature Communications. Stem Cell Research. 2017, [50] Yinxiong Li. Generation of a SMO Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-16 by using CRISPR/Cas9. Stem Cell Research. 2017, [51] Yinxiong Li. Generation of two MEN1 knockout lines from a human embryonic stem cell line, Stem Cell Research. Stem Cell Research. 2017, [52] Guo, Dongsheng, Liu, Haikun, Gao, Ge, Ruzi, Aynisahan, Wang, Kepin, Wu, Han, Lai, Keyu, Liu, Yanli, Yang, Fan, Lai, Liangxue, Li, Yinxiong. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9. STEM CELL RESEARCHnull. 2016, 17(3): 670-672, http://dx.doi.org/10.1016/j.scr.2016.11.014.
[53] Guo, Dongsheng, Liu, Haikun, Gao, Ge, Ruzi, Aynisahan, Wang, Kepin, Wu, Han, Lai, Keyu, Liu, Yanli, Yang, Fan, Lai, Liangxue, Li, Yinxiong. Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9. STEM CELL RESEARCHnull. 2016, 17(3): 640-642, http://dx.doi.org/10.1016/j.scr.2016.11.011.
[54] Zheng, Hui, Hutchins, Andrew Paul, Pan, Guangjin, Li, Yinxiong, Pei, Duanqing, Pei, Gang. Where cell fate conversions meet Chinese philosophy. CELL RESEARCH[J]. 2014, 24(10): 1162-1163, http://ir.gibh.ac.cn/handle/344009/281.
[55] Gourdie, Robert G, Myers, Tereance A, McFadden, Alex, Li, Yinxiong, Potts, Jay D. Self-Organizing Tissue-Engineered Constructs in Collagen Hydrogels. MICROSCOPY AND MICROANALYSIS[J]. 2012, 18(1): 99-106, https://www.webofscience.com/wos/woscc/full-record/WOS:000299757100009.
[56] Hua Mao, Anna Mae Diehl, YinXiong Li. Sonic Hedgehog Ligand Partners with Caveolin-1 for Intracellular Transportation. LABORATORY INVESTIGATION; A JOURNAL OF TECHNICAL METHODS AND PATHOLOGY. 2009, 89(3): 290-300, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647995/.
[57] Yang, Liu, Wang, Ying, Mao, Hua, Fleig, Susanne, Omenetti, Alessia, Brown, Kevin D, Sicklick, Jason K, Li, YinXiong, Diehl, Anna Mae. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. JOURNAL OF HEPATOLOGY[J]. 2008, 48(1): 98-106, http://dx.doi.org/10.1016/j.jhep.2007.07.032.
[58] Li, YinXiong, Yang, HaiTao, Zdanowicz, Marzena, Sicklick, Jason K, Qi, Yi, Camp, Terese J, Diehl, Anna Mae. Fetal alcohol exposure impairs hedgehog cholesterol modification and signaling. LABORATORY INVESTIGATION[J]. 2007, 87(3): 231-240, https://www.webofscience.com/wos/woscc/full-record/WOS:000244685700002.
[59] Wilbanks, AM, Fralish, GB, Kirby, ML, Barak, LS, Li, YX, Caron, MG. beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. SCIENCE[J]. 2004, 306(5705): 2264-2267, https://www.webofscience.com/wos/woscc/full-record/WOS:000225950000049.
[60] Kai You, Yan Wang, Xiaoxia Chen, Zhen Yang, Yan Chen, Shenglin Tan, Jiawang Tao, Anteneh Getachew, Tingcai Pan, Yingying Xu, Yuanqi Zhuang, Fan Yang, Xianhua Lin, Yinxiong Li. Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. http://dx.doi.org/10.1016/j.bbrc.2022.11.079.
发表著作
( 1 ) 现代分子生物学实验技术, 现代分子生物学实验技术, 高等教育出版社, 1993-07, 第 1 作者

科研活动

   
科研项目
( 1 ) 院启动项目, 主持, 市地级, 2011-09--2016-09
( 2 ) 干细胞修复动物肝病模型中受损肝组织 的方法及机理研究, 主持, 国家级, 2015-01--2019-08
( 3 ) 系统解析干细胞肝系分化及介导修复慢性肝纤维化的分子机制, 主持, 省级, 2015-07--2018-06
( 4 ) 血液黄曲霉毒素高效特异吸附材料的研发, 主持, 省级, 2015-10--2018-09
参与会议
(1)Stem cell biology and injured tissue repair   参加三城经济联盟2016奥克兰峰会   2016-05-16
(2)Adult liver stem cell identification, in vitro proliferation and function test in transplantation animal disease model   中国科学院-香港中文大学合作指导委员会第三次会议   2016-03-22
(3)肝脏干细胞修复慢性肝硬化的动物 模型研究   中国细胞生物治疗年会   2015-12-13
(4)肝脏干细胞修复慢性肝硬化的动物 模型研究   中英高层战略研讨会议   2015-12-03
(5)肝脏干细胞修复慢性肝硬化的动物 模型研究   国际生物研究进展会议   2015-11-03
(6)干细胞调控慢性肝损伤修复和再生 的动物模型探讨   第五届中澳生物医学研究大会   2015-10-30
(7)干细胞介导慢性肝损伤修复的动物 模型探讨   第六届广东省细胞生物 学学会学术年会暨第二 届广东省抗癌协会生物 治疗专业委员会学术年会   2015-10-24
(8)Liver adult stem and regeneration liver chronic diseases   2013-03-02
(9)Adult Hepatic Progenitor Cell and Injured Liver Regeneration in Fish Models   2012-10-03
(10)Hedgehog Signaling and tumorigenesis   2011-10-19
(11)Laser microdissection captured cells gene expression profile analysis hunting down ventral axis molecular players in vertebrates involved in three human genetic syndromes   2002-04-24
(12)issection of connecxin 43 promoter regulatory elements of tissue specificity   2001-08-16

指导学生

已指导学生

寇尚龙  02  63228  

现指导学生

伍飞马  01  19183  

郭东升  01  19183  

庄苑琦  02  19183  

徐莹莹  01  19183  

阿依妮萨罕·如则  02  19434  

谭圣林  02  19183  

柯欣荣  02  63228  

陶家旺  02  19183  

徐国胜  01  19183  

刘艳丽  01  19183  

熊月  01  19183  

潘廷才  01  19183  

工作经历

1985.07-1987.09        中国医学科学院基础所                       助理研究员

1991.07-1987.09         协和医科大学                                    助理教授

1992.10-1993.09         范德堡大学医学院                             博士后

1993.10-2001.03         乔治亚医学院                                    博士后

2001.04-2010.05         杜克大学医学院                                 助理教授

2010.06-2011.05         南卡罗莱纳医科大学                           副教授

2011.06-2012.05         美国SMT公司                                     首席技术官/副总裁

2012.05-至今              中科院广州生物医药与健康研究院        研究员/国家**A类